Send mail to Author

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   _      ___      ______    ______    ____     __   __  
| || | ||   / _ \\   /_   _//  /_   _//  |  _ \\   \ \\/ // 
| '--' ||  | / \ ||  `-| |,-    -| ||-   | |_| ||   \ ` //  
| .--. ||  | \_/ ||    | ||     _| ||_   | .  //     | ||   
|_|| |_||   \___//     |_||    /_____//  |_|\_\\     |_||   
`-`  `-`    `---`      `-`'    `-----`   `-` --`     `-`'
 


Back to frontdoor view

OPUS4 Logo